GLOBAL BLOOD THERAPEUTICS, INC. Item 5.07 Submission of Matters to a Vote of Security Holders.
The proposals set forth below were submitted to the stockholders at the 2022
Annual Meeting of Stockholders, or Annual Meeting, of
The number of shares of common stock entitled to vote at the Annual Meeting was 65,098,164. The number of shares of common stock present or represented by valid proxy at the Annual Meeting was 54,401,804. The number of votes cast for and against and the number of abstentions and broker non-votes with respect to each proposal voted upon are set forth below.
Proposal 1 - Election of Directors
Our stockholders elected the Class I director nominees below to our Board of Directors to hold office until the 2025 Annual Meeting of Stockholders or until their successors are duly elected and qualified.
Director Nominee Votes For Votes Withheld Ted W. Love, M.D. 40,144,676 8,585,291 Glenn F. Pierce, M.D., Ph.D. 40,352,391 8,377,576 Dawn A. Svoronos 29,383,996 19,345,971
There were 5,671,837 broker non-votes regarding this proposal.
Proposal 2 - Approval, on a Non-Binding, Advisory Basis, of the Compensation of the Company's Named Executive Officers as Disclosed in the Proxy Statement
Our stockholders approved, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement.
Votes For Votes Against Abstentions 46,274,486 2,435,500 19,981
There were 5,671,837 broker non-votes regarding this proposal.
Proposal 3 - Ratification of Appointment of Independent Registered Accounting Firm
Our stockholders ratified the appointment of
Votes For Votes Against Abstentions 54,244,583 142,281 14,940
There were no broker non-votes regarding this proposal.
--------------------------------------------------------------------------------
© Edgar Online, source
